Trial · NCT05690698
Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
NCT05690698, Phase 3, Completed, Alexandria University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium. Trials, record NCT05690698. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05690698
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Quetiapine Versus Haloperidol in the Management of Hyperactive Delirium
- NCT number
- NCT05690698
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 100 participants, actual
- Lead sponsor
- Alexandria University
- Conditions
- Hyperactive Delirium
- Interventions
- Quatiapine, Haloperidol
- First posted
- 2023-01-19
- Last updated
- 2023-08-30
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Response rate | Day 7 | Response rate is defined as a reduction of the DRS-R-98 severity score from its baseline for 50% or more and a DRS-R-98 severity score of 12 or less without relapse |
| Secondary | In-hospital mortality | week 6 from enrollment | In-hospital all cause mortality |
| Secondary | ICU-mortality | week 6 from enrollment | ICU all cause mortality |
| Secondary | Need for MV | week 6 from enrollment | Need for mechanical ventilation during ICU stay |
| Secondary | ICU stay | week 6 from enrollment | Number of days of ICU stay |
| Secondary | Hospital stay | week 6 from enrollment | Number of days of hospital stay |
| Other | Sleeping hours | Day 3 | Sleeping hours per night |
| Other | Sleeping hours | Day 7 | Sleeping hours per night |
| Other | Delirium Rating Scale-revised-98 severity score | Day 3 | The DRS-R-98 is a valid measure of delirium severity over a broad range of symptoms and is a useful diagnostic and assessment tool, maximum severity score of 39 points |
| Other | Delirium Rating Scale-revised-98 severity score | Day 7 | The DRS-R-98 is a valid measure of delirium severity over a broad range of symptoms and is a useful diagnostic and assessment tool, maximum severity score of 39 points |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05690698
GET https://conductscience.org/api/trials/v1/NCT05690698/registered